GHK-Cu: A Copper Carrier for the Repair Matrix

The short version

GHK-Cu is a very small peptide — three amino acids (glycine, histidine, lysine) — bound to a single copper ion. You will also see it called copper tripeptide-1. The same GHK sequence occurs naturally inside type I collagen, the main structural protein of skin and tendon, which is a clue to what it does: it signals skin and connective-tissue cells to rebuild their scaffolding of collagen and elastin ^[16].

Of the four peptides here, GHK-Cu has the most human evidence — but that evidence is mostly topical, meaning creams and serums applied to the skin surface, and it has a built-in catch: the peptide does not cross intact skin well on its own ^[13]. Topical copper-peptide cosmetics are legal and widely sold; injectable or whole-body use is unapproved and research-only ^[13]. This page summarizes the studies and recommends no dose or regimen.

What it is

GHK-Cu is a linear tripeptide, glycyl-L-histidyl-L-lysine, chelated (bound in a stable claw-like grip) one-to-one to a copper(II) ion. The copper is held by the histidine ring, the glycine amino group, and a backbone nitrogen, leaving the lysine side chain free. It carries a small positive charge. The bare GHK sequence appears endogenously within the alpha-2(I) chain of type I collagen and in a matrix protein called SPARC/osteonectin — so the body already uses this motif, and copper coordination is required for most of its reported activity ^[16].

How it works

GHK-Cu plays two roles at once: it is a copper chaperone (a carrier that delivers copper where it is needed) and a broad signaling molecule. At very low — picomolar to nanomolar — concentrations it directly tells dermal fibroblasts (the skin's matrix-making cells) to synthesize collagen, elastin, glycosaminoglycans and the proteoglycan decorin, while rebalancing the enzymes that break matrix down (matrix metalloproteinases) against their natural inhibitors (TIMPs) ^[16]. The copper ion itself enables lysyl-oxidase-mediated cross-linking that knits collagen and elastin together, plus a superoxide-dismutase-like antioxidant action.

Its effects also reach the gene level. A Connectivity Map gene-expression analysis reported that GHK shifts expression of roughly 31.2% of human genes at a 50%-or-greater change threshold (about 59% up, 41% down), strongly stimulating the protein-quality-control (ubiquitin-proteasome) system and DNA-repair and antioxidant gene sets ^[14]. One honest correction belongs here: the widely repeated "~4,000 genes" figure is an extrapolation; the verified 50%-threshold table reports on the order of 2,100 genes ^[14].

What the research shows

Skin regeneration. The canonical review documents GHK-Cu stimulating synthesis of collagen, dermatan sulfate, chondroitin sulfate and decorin, notes that plasma GHK falls from about 200 ng/mL at age 20 to about 80 ng/mL by age 60, and reports that topical GHK-Cu increased collagen production in 70% of treated women versus 50% for vitamin C and 40% for retinoic acid ^[16].

Gene expression. The 2018 analysis quantified the broad transcriptomic shift toward tissue-repair, protein-quality-control, DNA-fidelity and antioxidant programs ^[14].

A controlled human signal. In a 6-month trial of 45 men with male-pattern hair loss, a complex of 5-aminolevulinic acid plus glycyl-histidyl-lysine peptide increased hair count by 52.6 (at 100 mg/mL) and 71.5 (at 50 mg/mL) versus only 9.6 for placebo, with no adverse events in any group — the strongest controlled human efficacy signal for a GHK-containing topical, though it is a combination product, not pure GHK-Cu ^[15].

The delivery problem. A 2025 review confirms GHK's poor skin permeability is the central challenge: it reports procollagen synthesis up in 70% of GHK-Cu-treated subjects (versus 50% for vitamin C, 40% for retinoic acid) and evaluates fixes such as palmitoylation and microneedle pretreatment (about 134 nmol GHK permeated with microneedling versus none through intact skin) ^[13]. A separate human skin-penetration study quantified copper delivery from GHK-Cu through dermatomed skin, with a measurable dermal copper depot forming over 48 hours ^[17].

Reported effects, cautions & safety

Topical copper-peptide products carry a long real-world safety record, but several cautions are well documented:

• No approved drug indication. There is no FDA- or EMA-approved therapeutic GHK-Cu product by any route. Topical copper tripeptide-1 is a legal cosmetic ingredient; injectable or systemic use is unapproved and research-only ^[13].
• Thin human evidence beyond skin. Human clinical data are limited to small topical dermatology trials and the single 45-patient combination hair-loss study — there is no validated human pharmacokinetic data for injectable or systemic GHK-Cu, so community dosing protocols have no peer-reviewed basis ^[15].
• Pigmentation. Localized hyperpigmentation (skin darkening) has been reported with some topical copper-peptide applications — for example around 40% in one acne-scar microneedling study.
• Formulation incompatibility. Vitamin C / ascorbic acid and low-pH acids can destroy both actives through copper interactions — a real user-error risk.
• Theoretical copper accumulation. Prolonged systemic use raises a theoretical copper-balance concern, though no human copper-toxicity cases attributed to GHK-Cu appear in the peer-reviewed record.
• Single-investigator origin. A large share of foundational mechanistic and review literature comes from one investigator and colleagues, limiting independent replication of the broader anti-aging and gene-expression claims ^[14].

No community-anecdote reports are compiled in this desk's source material for GHK-Cu, so none are presented; the cautions above come from the cited literature.

Where it fits in recovery research

GHK-Cu is the matrix-and-skin specialist of the group, and the one with the strongest human footing — but that footing is mostly on the skin surface, where its own delivery problem caps how far the evidence reaches ^[13]. Where BPC-157 and TB-500 live almost entirely in animal models, GHK-Cu has decades of topical cosmetic use behind it; what it lacks is validated systemic human data. It rounds out the desk's repair picture with the scaffolding angle — the actual rebuilding of collagen and elastin. Compare all four on the comparison page.